Skip to main content
. 2019 Oct 4;9:14308. doi: 10.1038/s41598-019-50488-3

Table 1.

Clinical characteristics of a general Korean population used in this study (n = 282,135).

BMI category P value
Underweight (n = 15,462) Normal (n = 188,490) Obese (n = 78,183)
Sex
  Female (%) 87.9 52.2 22.9 <0.001
  Male (%) 12.1 47.8 77.1
Age (years) 35.4 ± 7.8 39.6 ± 9.3 41.0 ± 9.3 <0.001
BMI (kg/m2) 17.6 ± 0.7 22.0 ± 1.8 27.4 ± 2.2 <0.001
Glucose (mg/dl) 88.9 ± 9.2 93.7 ± 13.1 100.1 ± 18.3 <0.001
Total cholesterol (mg/dl) 179.2 ± 28.9 191.5 ± 33.0 204.5 ± 35.6 <0.001
Triglyceride (mg/dl) 67.7 ± 28.0 98.1 ± 62.2 153.0 ± 98.0 <0.001
HDL-C (mg/dl) 70.6 ± 14.4 60.4 ± 14.6 50.2 ± 12.0 <0.001
LDL-C (mg/dl) 98.5 ± 24.6 116.4 ± 30.6 131.6 ± 32.0 <0.001
Albumin (g/dl) 4.56 ± 0.2 4.55 ± 0.2 4.58 ± 0.2 <0.001
Total protein (g/dl) 7.29 ± 0.4 7.26 ± 0.4 7.31 ± 0.4 <0.001
HbA1c (%) 5.5 ± 0.3 5.6 ± 0.4 5.8 ± 0.6 <0.001
Fasting insulin (uIU/ml) 4.0 ± 2.2 5.3 ± 4.6 8.8 ± 5.5 <0.001
hsCRP (mg/L) 0.07 ± 0.42 0.09 ± 0.30 0.15 ± 0.33 <0.001
Height (cm) 163.2 ± 6.4 166.5 ± 8.4 169.9 ± 8.3 <0.001
Weight (kg) 47.0 ± 4.2 61.3 ± 8.8 79.2 ± 10.1 <0.001
Waist circumference (cm) 66.5 ± 3.9 78.4 ± 6.5 92.1 ± 6.6 <0.001
SBP (mmHg) 97.3 ± 9.5 105.1 ± 12.1 115.2 ± 12.4 <0.001
DBP (mmHg) 63.8 ± 7.9 68.2 ± 9.5 74.7 ± 10.1 <0.001
Smoking (pack-year) 1.2 ± 4.7 3.8 ± 7.7 7.2 ± 9.7 <0.001
Smoking
  Never smoked (%) 86.3 64.9 43.1 <0.001
  Former smoker (%) 5.6 16.2 24.6
  Current smoker (%) 8.1 18.8 32.3
Vigorous exercise (times/week) 0.6 ± 1.3 0.9 ± 1.5 1.0 ± 1.5 <0.001
Hypertension (%) 1.3 6.1 16.8 <0.001
Diabetes (%) 0.6 2.1 4.8 <0.001
HOMA-IR 0.9 ± 0.5 1.2 ± 1.1 2.2 ± 1.7 <0.001

Data are presented as percentage or mean ± standard deviation.

BMI categories: normal (between 18.5 and 25 kg/m2), underweight (<18.5 kg/m2), and obese (≥25 kg/m2).

BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HbA1c, glycated hemoglobin; hsCRP, high-sensitivity C-reactive protein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HOMA-IR, homeostasis model assessment of insulin resistance.